Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Brian C. Davis"'
Autor:
Thananya Jinato, Masoumeh Sikaroodi, Andrew Fagan, Richard K Sterling, Hannah Lee, Puneet Puri, Brian C Davis, Michael Fuchs, Edith Gavis, Patrick M Gillevet, Jasmohan S Bajaj
Publikováno v:
Gut Microbes, Vol 15, Iss 2 (2023)
ABSTRACTCognitive dysfunction due to minimal hepatic encephalopathy (MHE) adversely impacts patients with cirrhosis and more precise therapies are needed. Gut-brain axis changes are therapeutic targets, but prior studies have largely focused on bacte
Externí odkaz:
https://doaj.org/article/12e2bb4cf2af4065a1c7352a1baa11ed
Autor:
Jasmohan S Bajaj, Marcela Peña-Rodriguez, Alex La Reau, Wendy Phillips, Michael Fuchs, Brian C Davis, Richard K Sterling, Masoumeh Sikaroodi, Andrew Fagan, Amirhossein Shamsaddini, Zachariah Henseler, Tonya Ward, Puneet Puri, Hannah Lee, Patrick M Gillevet
Publikováno v:
Gut. 72:759-771
ObjectiveFirst decompensation development is a critical milestone that needs to be predicted. Transkingdom gut microbial interactions, including archaeal methanogens, may be important targets and predictors but a longitudinal approach is needed.Desig
Autor:
Jasmohan S. Bajaj, Marcela Peňa Rodriguez, Andrew Fagan, Sara McGeorge, Richard K. Sterling, Hannah Lee, Velimir Luketic, Michael Fuchs, Brian C. Davis, Masoumeh Sikaroodi, Patrick M. Gillevet
Publikováno v:
Hepatology. 76:1723-1734
Gut microbiota, including bacteria and phages, are altered in cirrhosis, but their role during infections and spontaneous bacterial peritonitis (SBP) prophylaxis is unclear. Our aim was determine metagenomic changes in gut bacteria; phages and their
Autor:
Thoetchai Peeraphatdit, Patrick S. Kamath, Camille A. Kezer, Vijay H. Shah, Douglas A. Simonetto, Daniel D. Penrice, Brian C. Davis, Serena Shah, Kristin C. Mara, Arun J. Sanyal
Publikováno v:
Hepatology Communications, Vol 5, Iss 12, Pp 2096-2103 (2021)
Hepatology Communications
Hepatology Communications
Alcohol‐associated hepatitis (AAH) is a severe form of liver injury with mortality as high as 30%‐40% at 90 days. As a result of altered immune function in AAH, bacterial infections are common and are associated with poor outcomes. However, deter
Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis
Autor:
April Morris, Dan Park, Brian C. Davis, Jasmohan S. Bajaj, Andrew J. Fagan, Mary L. Gallagher, Zenaida Malpaya, Shreesh Shrestha, Omer Shahab, Nikki Duong
Publikováno v:
Am J Gastroenterol
Bowel movement (BM) frequency is used to titrate lactulose for hepatic encephalopathy (HE). However, stool consistency using the Bristol stool scale (BSS, 0-7) is often ignored.The study included pre-BSS and post-BSS cohorts. BSS was incorporated int
Autor:
Samarth Patel, Masoumeh Sikaroodi, Brian C. Davis, Jasmohan S. Bajaj, James B. Wade, Michael Fuchs, Patrick M. Gillevet, Jill G. Meador, Leroy R. Thacker, Edith Gavis, Andrew Fagan, Puneet Puri
Publikováno v:
Hepatology. 73:1688-1700
Background and aims Alcohol use disorder (AUD) is associated with microbial alterations that worsen with cirrhosis. Fecal microbiota transplant (FMT) could be a promising approach. Approach and results In this phase 1, double-blind, randomized clinic
Autor:
Tammy L. Eaton, Anna Lewis, Heidi S. Donovan, Brian C. Davis, Brad W. Butcher, Sheila A. Alexander, Theodore J. Iwashyna, Leslie P. Scheunemann, Jennifer Seaman
Publikováno v:
Intensivecritical care nursing.
To examine the needs of adult survivors of critical illness through a lens of palliative care.A qualitative study of adult survivors of critical illness using semi-structured interviews and framework analysis.Participants were recruited from the post
Publikováno v:
Journal of the American Ceramic Society. 103:7135-7146
Publikováno v:
Journal of Gastrointestinal Cancer. 52:332-335
Autor:
Chandrashekhar A. Kubal, Brian C. Davis, Kavish R. Patidar, William M. Lee, Richard T. Stravitz, Marwan Ghabril, James E. Slaven
Publikováno v:
Digestive Diseases and Sciences. 66:619-627
Traditional laboratory markers are insensitive in distinguishing between patients with acute liver failure (ALF) who will require urgent liver transplantation (LT) from those who will recover spontaneously, particularly within 24 h of presentation. C